News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Derma Sciences, Inc. (DSCI) Launches MEDIHONEY® HCS in the U.S.


9/6/2012 10:19:06 AM

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the U.S. launch and first commercial sales of MEDIHONEY® HCS (Hydrogel Colloidal Sheet), the latest in the MEDIHONEY line of advanced wound care products. MEDIHONEY® HCS is a patented dressing comprising a combination of the Company’s MEDIHONEY® and XTRASORB® HCS dressings. The product will be available for the treatment of first- and second-degree burns, in addition to various chronic and acute wounds.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES